The NICHD has highlighted the UCSF Hydrops study in their recent article "Promoting Healthy Pregnancy, Labor, and Delivery"
News


New webinar from the UCSF Fetal Treatment Center: Placenta accreta spectrum disorder is a varied and increasingly common complication of pregnancy, so ob/gyns need a firm grasp of risk factors and ultrasound signs. A multidisciplinary panel of specialists from the UCSF Fetal Treatment Center explains how they handle patients to maximize outcomes, with a case-based review that illuminates their steps to evaluation and treatment.

The cause of most fetal anomalies is not determined prenatally. Exome sequencing has transformed genetic diagnosis after birth, but its usefulness for prenatal diagnosis is still emerging. Nonimmune hydrops fetalis (NIHF), a fetal abnormality that is often lethal, has numerous genetic causes; the extent to which exome sequencing can aid in its diagnosis is unclear.

A new study by University of California researchers shows the promise of high-throughput DNA-sequencing technologies to improve prenatal diagnosis and pregnancy outcomes for women who have experienced an abnormal prenatal ultrasound.